No significant change in the ratio of total CD8+ to CD4+ T cells was observed at day 14 post-tumor implant whereas a significant increase was achieved in animals treated with a single dose of 1 mg/kg 4-1BB mAb (p = 0.0193) at day 22 post-tumor implant (Figure 3a). Here, CD4 is linked to neoplasm.